To eliminate confounding effects of stable HMOX1 KO on tumor progression, we established Hmox1-inducible knockdown cell lines based on a doxycycline-inducible shRNA expression system (Supplemental Figure 2C). The gene discussed is HMOX1; the disease is neoplasm.